http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-035278-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_491cdd9579fb3948b1e16a0b7e2f9feb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-32 |
| filingDate | 2017-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9377c0728eb424ad1016bb52cd265cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaaa4a4db84f3a14bacb877ff3ce0de5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aabd4a17a9da026c8a759cbe1991aa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e25cde3a9fe396ad9f509e632ab7c966 |
| publicationDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-035278-B1 |
| titleOfInvention | METHOD FOR PRODUCING TAMERIT AND / OR GALAVIT STERILE LYOPHYLIZED MEDICINE BASED ON 5-AMIN-2,3-DIHYDROPHTHALAZINE-1,4-DIUMORIUM SODIUM SULFUM AND TODIUM SODIUM 2,3-DIHYDROFTALAZINE-1,4-DIONE (GALAVIT) |
| abstract | The invention relates to medicine, namely to medicines affecting the immune system and having immunomodulatory, anti-inflammatory, antitumor and antioxidant effects, as well as to the chemical and pharmaceutical production of these drugs. A method for producing a sterile lyophilized drug based on the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione by processing anhydrous and / or two-water non-sterile substance of the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4 -dione, which is characterized in that they realize the process of processing the intermediate product of 5-amino-2,3-dihydrophthalazine-1,4-dione into its sodium salt by dissolving in an aqueous-organic alkaline solution so that an anhydrous and / or two-aqueous substance of sodium salts of 5-amino-2,3-dihydrophthalazine-1,4-dione are obtained by crystallization at a temperature of minus 5-7 ° C from an aqueous-organic solution of the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione, after which from the substance receive a sterile lyophilized drug. |
| priorityDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.